23562514|t|Xanthoceraside attenuates learning and memory deficits via improving insulin signaling in STZ-induced AD rats.
23562514|a|Xanthoceraside, a triterpenoid saponin extracted from the fruit husks of Xanthoceras sorbifolia Bunge, has been shown to reverse the cognitive deficits observed in several Alzheimer's disease (AD) animal models. Increasing evidence suggests the involvement of the insulin signaling pathway in neurodegenerative disorders such as AD. Thus, we used an AD animal model of cognitive impairment induced by the intracerebroventricular (ICV) injection of streptozotocin (STZ) to test the effects of xanthoceraside on behavioral impairments and insulin signaling mechanisms. In our present study, memory impairment was assessed using the Morris water maze test. The expression of IR, IGF-1R and Raf-1/ERK/CREB was tested by western blotting. The STZ group showed memory deficits in the Morris water maze test and significant decreases in IR and IGF-1R protein levels in the hippocampus. Xanthoceraside treatment significantly rescued memory deficits, as well as IR and IGF-1R protein expression levels. STZ inhibited the Ras/ERK signaling cascade and decreased the phosphorylation of CREB; these effects were also attenuated by xanthoceraside treatment. These results suggest the potential use of xanthoceraside for the treatment of neurodegenerative disorders in which brain insulin signaling may be involved.
23562514	0	14	Xanthoceraside	Chemical	MESH:C548611
23562514	26	54	learning and memory deficits	Disease	MESH:D007859
23562514	90	93	STZ	Chemical	MESH:D013311
23562514	102	104	AD	Disease	MESH:D000544
23562514	105	109	rats	Species	10116
23562514	111	125	Xanthoceraside	Chemical	MESH:C548611
23562514	129	149	triterpenoid saponin	Chemical	-
23562514	184	212	Xanthoceras sorbifolia Bunge	Species	
23562514	244	262	cognitive deficits	Disease	MESH:D003072
23562514	283	302	Alzheimer's disease	Disease	MESH:D000544
23562514	304	306	AD	Disease	MESH:D000544
23562514	404	431	neurodegenerative disorders	Disease	MESH:D019636
23562514	440	442	AD	Disease	MESH:D000544
23562514	461	463	AD	Disease	MESH:D000544
23562514	480	500	cognitive impairment	Disease	MESH:D003072
23562514	559	573	streptozotocin	Chemical	MESH:D013311
23562514	575	578	STZ	Chemical	MESH:D013311
23562514	603	617	xanthoceraside	Chemical	MESH:C548611
23562514	621	643	behavioral impairments	Disease	MESH:D001523
23562514	700	717	memory impairment	Disease	MESH:D008569
23562514	787	793	IGF-1R	Gene	25718
23562514	798	803	Raf-1	Gene	24703
23562514	804	807	ERK	Gene	24338
23562514	808	812	CREB	Gene	81646
23562514	849	852	STZ	Chemical	MESH:D013311
23562514	866	881	memory deficits	Disease	MESH:D008569
23562514	948	954	IGF-1R	Gene	25718
23562514	990	1004	Xanthoceraside	Chemical	MESH:C548611
23562514	1037	1052	memory deficits	Disease	MESH:D008569
23562514	1072	1078	IGF-1R	Gene	25718
23562514	1106	1109	STZ	Chemical	MESH:D013311
23562514	1128	1131	ERK	Gene	24338
23562514	1187	1191	CREB	Gene	81646
23562514	1231	1245	xanthoceraside	Chemical	MESH:C548611
23562514	1300	1314	xanthoceraside	Chemical	MESH:C548611
23562514	1336	1363	neurodegenerative disorders	Disease	MESH:D019636
23562514	Negative_Correlation	MESH:D013311	25718
23562514	Negative_Correlation	MESH:D013311	81646
23562514	Negative_Correlation	MESH:C548611	MESH:D000544
23562514	Negative_Correlation	MESH:C548611	MESH:D008569
23562514	Positive_Correlation	MESH:D013311	MESH:D003072
23562514	Negative_Correlation	MESH:C548611	MESH:D001523
23562514	Negative_Correlation	MESH:C548611	81646
23562514	Negative_Correlation	MESH:C548611	MESH:D007859
23562514	Negative_Correlation	MESH:C548611	MESH:D019636
23562514	Positive_Correlation	MESH:D013311	MESH:D008569
23562514	Positive_Correlation	MESH:D013311	MESH:D000544
23562514	Association	MESH:C548611	24338
23562514	Negative_Correlation	MESH:C548611	25718
23562514	Negative_Correlation	MESH:C548611	MESH:D003072
23562514	Negative_Correlation	MESH:D013311	24338
23562514	Negative_Correlation	MESH:C548611	MESH:D013311

